Harmony Biosciences acquires Epygenix Therapeutics, Inc. to expand rare epilepsy franchise
04/30/24, 11:08 AM
Location
plymouth meetingparamusIndustry
therapeutics
biotechnology
health care
biopharma
therapeutics
biotechnology
health care
Harmony Biosciences has announced the acquisition of Epygenix Therapeutics, Inc., adding a late-stage epilepsy franchise to its growing pipeline of innovative CNS assets. With the acquisition, Harmony Biosciences aims to leverage its expertise and synergies to accelerate the development and commercialization of potential therapies for rare epilepsy conditions, emphasizing its commitment to addressing unmet medical needs in the neurological disorder space.
Company Info
Location
Plymouth Meeting, Pennsylvania, United States
Company info
At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook. We believe that where empathy and innovation meet, a better life can begin for people living with neurological diseases. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, our team of experts from a wide variety of disciplines and experiences is driven by our shared conviction that innovative science translates into therapeutic possibilities for our patients, who are at the heart of everything we do.